Under construction – not a live service
Sign in

NCT07030868TerminatedPhase 2

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

A Phase 2, Parallel-Group, Double-Blind 4-arm Study to Investigate the Effects of Treatment With LY3549492 Tablets Compared With Placebo in an Obese or Overweight Population With Type-2 Diabetes (T2D)

Source: ClinicalTrials.gov · Last updated 31 Aug 2026

Reason given: Study terminated for strategic business reasons

Brief summary (registry, in English)

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes. Participation in the study will last about 11 months.

Status (registry)
Terminated
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
1 (actual)
First submitted
13 Jun 2025
Start date
19 Jun 2025
Primary completion date
29 Jul 2025
Lead sponsor
Eli Lilly and Company
NCT number
NCT07030868

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have any of the following cardiovascular conditions within 6 months prior to screening:
    • acute myocardial infarction
    • cerebrovascular accident (stroke)
    • unstable angina, or
    • hospitalization due to congestive heart failure.
    • W8M-MC-CWMM:
  • Have a prior or planned surgical treatment for obesity, except prior liposuction or abdominoplasty, if performed >1 year prior to screening

Other illness

  • Have a history of acute or chronic pancreatitis
  • Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history of ketoacidosis or hyperosmolar coma
  • Have poorly controlled hypertension
  • Have signs and symptoms of any liver disease other than nonalcoholic fatty liver disease
  • Have a history of symptomatic gallbladder disease within the past 2 years
  • Have a lifetime history of suicide attempts

Other

  • W8M-MC-GN02:
  • Individuals who are of childbearing potential

Who the study is looking for

  • W8M-MC-GN02:
  • Assigned male at birth
  • Assigned female at birth, who are of non-childbearing potential
  • Have type 2 diabetes
    • W8M-MC-CWMM:
  • Have a BMI ≥27 kilograms per square meter (kg/m²)
  • Have had a stable body weight for the 3 months prior to randomization (<5% body weight gain and/or loss

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (42)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Centro Médico ViamonteBuenos AiresArgentinaUnknown status
Centro Medico Dra. Laura Maffei- Investigacion Clinica AplicadaBuenos AiresArgentinaUnknown status
Consultorio de Investigación Clínica EMO SRLBuenos AiresArgentinaUnknown status
Centro de Investigaciones Metabólicas (CINME)Buenos AiresArgentinaUnknown status
Medical Research PartnersAmmonUnited StatesUnknown status
IMA Clinical Research AustinAustinUnited StatesUnknown status
Great Lakes Clinical Trials - RavenswoodChicagoUnited StatesUnknown status
FutureSearch Trials of DallasDallasUnited StatesUnknown status
Velocity Clinical Research, DallasDallasUnited StatesUnknown status
Spectrum Medical, Inc.DanvilleUnited StatesUnknown status
Velocity Clinical Research, SyracuseEast SyracuseUnited StatesUnknown status
Northeast Research Institute (NERI)Fleming IslandUnited StatesUnknown status
NorCal Medical Research, IncGreenbraeUnited StatesUnknown status
Indago Research & Health Center, IncHialeahUnited StatesUnknown status
PlanIt Research, PLLCHoustonUnited StatesUnknown status
Velocity Clinical Research-Huntington ParkHuntington ParkUnited StatesUnknown status
Las Vegas Medical ResearchLas VegasUnited StatesUnknown status
New Horizon Research CenterMiamiUnited StatesUnknown status
Monroe Biomedical ResearchMonroeUnited StatesUnknown status
Lucas Research, Inc.Morehead CityUnited StatesUnknown status
Quality Medical ResearchNashvilleUnited StatesUnknown status
KnownwellNeedhamUnited StatesUnknown status
Lucida Clinical TrialsNew BedfordUnited StatesUnknown status
Lucas Research, Inc.New BernUnited StatesUnknown status
Suncoast Clinical Research, Inc.New Port RicheyUnited StatesUnknown status
Charter Research - Winter ParkOrlandoUnited StatesUnknown status
Hope Research InstitutePhoenixUnited StatesUnknown status
Rochester Clinical Research, LLCRochesterUnited StatesUnknown status
Peninsula Research AssociatesRolling Hills EstatesUnited StatesUnknown status
Endeavor Clinical TrialsSan AntonioUnited StatesUnknown status
Tekton Research - Fredericksburg RoadSan AntonioUnited StatesUnknown status
Headlands Research - ScottsdaleScottsdaleUnited StatesUnknown status
Headlands Research - DetroitSouthfieldUnited StatesUnknown status
Clinvest Headlands LLCSpringfieldUnited StatesUnknown status
Stamford Therapeutics ConsortiumStamfordUnited StatesUnknown status
Charter Research - Lady LakeThe VillagesUnited StatesUnknown status
Cotton O'Neil Diabetes & EndocrinologyTopekaUnited StatesUnknown status
Arcturus Healthcare , PLC, Troy Internal Medicine Research DivisionTroyUnited StatesUnknown status
Diablo Clinical Research, Inc.Walnut CreekUnited StatesUnknown status
Central Washington Health Services Association d/b/a Confluence HealthWenatcheeUnited StatesUnknown status
Texas Valley Clinical ResearchWeslacoUnited StatesUnknown status
Iowa Diabetes and Endocrinology Research CenterWest Des MoinesUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.